Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …

Coronaviruses are constantly circulating in humans, causing common colds and mild
respiratory infections. In contrast, infection with the novel severe acute respiratory syndrome …

The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …

Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is a novel coronavirus
that causes coronavirus disease 19 (COVID‐19), which has infected millions of people …

The prevalence of nonalcoholic fatty liver disease (NAFLD) has increased significantly over
the last few decades mirroring the increase in obesity and type II diabetes mellitus. NAFLD …

Liver involvement, indicated by elevated liver function test results, is common in hospitalized
patients with coronavirus disease 2019 (COVID‐19) and has been linked to disease severity …

Recently, Fondevila and colleagues1 reported that individuals with non-alcoholic
steatohepatitis (NASH), one of the more severe manifestations of non-alcoholic fatty liver …

The global population is currently experiencing the impact of the SARS-CoV-2 coronavirus,
which has caused the Coronavirus Disease 2019 (COVID-19) pandemic. With our profound …

Obesity has been recognized as an independent risk factor for critical illness and major
severity in subjects with coronavirus disease 2019 (COVID-19). The role of fat distribution …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a multi-organ
damage that includes hepatic dysfunction, which has been observed in over 50% of COVID …